Objective Serotonergic psychedelics are re-emerging as potential novel treatments for
several psychiatric disorders including major depressive disorder. The Canadian Network …

Since decades, lithium and valproate remain the pharmacological cornerstone to treat
bipolar disorder. Different response patterns occur according to the phases of illness. At …

Psicofármacos: consulta rápida é um livro essencial que chega à sua 6ª edição, sendo
referência junto a psiquiatras brasileiros e presença obrigatória nos consultórios médicos e …

Background Bipolar disorder is a mood dysregulation characterized by recurrent symptoms
and episodes of mania, hypomania, depression, and mixed mood. The complexity of treating …

The objective of this study was to compare recommendations of the Korean Medication
Algorithm Project for Bipolar Disorder 2022 (KMAP-BP 2022) with other recently published …

Background To review the phenomenology, nosology, and treatment of postpartum
psychosis. Methods Using the keywords postpartum, puerperal, psychosis, bipolar, mania …

Objective We revised the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-
BP), first published in 2002 and revised in 2006, 2010, 2014, and 2018, to reflect recent …

Introduction Agitation is commonly encountered in people with bipolar disorder, particularly
when experiencing a manic episode. The number of approved pharmacological agents to …

Objectives We performed a network meta-analysis (NMA) with up-to-date evidence to
compare different anti-inflammatory agents to improve the treatment of bipolar disorder (BD) …

Effective pharmacotherapy of bipolar depression with mixed features defined by DSM-5
remains unclear in clinical treatment guidelines. Quetiapine (QTP) and valproate have …